Multiomic characterization and drug testing establish circulating tumor cells as an ex vivo tool for personalized medicine.
Chen JY, Chou HH, Lim SC, Huang YJ, Lai KC, Guo CL, Tung CY, Su CT, Wang J, Liu E, Han HF, Yeh PY, Hu CM, Dunn AR, Frank CW, Wu YC, Yang MH, Chang YC.
Chen JY, et al. Among authors: chang yc.
iScience. 2022 Sep 6;25(10):105081. doi: 10.1016/j.isci.2022.105081. eCollection 2022 Oct 21.
iScience. 2022.
PMID: 36204272
Free PMC article.